BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 10, 2014
View Archived Issues
Mechanistic characterization of a dual function anti-inflammatory and proapoptotic drug
Read More
Preclinical development of AIC-649 as a new strategy for the treatment of chronic viral infections
Read More
Synageva provides enrollment updates on studies of enzyme replacement therapy for LAL deficiency
Read More
Eddingpharm acquires rights to several oncology assets from ACT Biotech
Read More
FDA accepts LabCorp's IDE for companion diagnostic test for ARCA biopharma's Gencaro
Read More
Apitope-led consortium receives funding to develop therapeutic vaccine for Graves' disease
Read More
Labrys Biologics begins two phase II studies of LBR-101 in chronic and episodic migraine
Read More
SOM-0226 receives FDA orphan drug designation for transthyretin amyloidosis
Read More
Targazyme presents data for ASC-101, a human recombinant enzyme-based therapy
Read More
IGN-532 shows preclinical efficacy in xenograft models of AML
Read More
Leica Biosystems to develop companion diagnostic for Arno's targeted oncology therapy onapristone
Read More
Proteon obtains E.U. orphan drug status for PRT-201 for hemodialysis vascular access
Read More
Neumedicines' HemaMax shown to improve survival outcomes following lethal irradiation
Read More
FDA approves Isentress pediatric oral suspension
Read More
Adheron Therapeutics reports phase I data for SDP-051
Read More
EMA grants accelerated review to Bristol-Myers' MAA for daclatasvir in chronic HCV
Read More
Fenfluramine obtains orphan drug designation in the U.S. and E.U. for Dravet syndrome
Read More
FLINT trial stopped early for efficacy in NASH
Read More
The Mayo Foundation discloses new STAT3 inhibitors for cancer
Read More
Aggredyne gains FDA clearance for AggreGuide A-100 instrument and AA Assay
Read More
Sanofi prepares novel dual GLP-1 and GL-R agonists
Read More
Chinese researchers disclose novel antimycobacterial agents
Read More
Sage Therapeutics synthesizes novel GABA(A) receptor modulators
Read More
Five Prime Therapeutics enters into antibody collaboration with Adimab
Read More
Hangzhou Bensheng Pharmaceutical patents new saponins for cancer
Read More
Crystal Bioscience and Boehringer Ingelheim enter therapeutic antibody collaboration
Read More